Search
Search Results
-
Recanalization of port-superior mesenteric vein thrombosis with long-term anticoagulant therapy after failed early anticoagulant therapy
BackgroundAnticoagulant therapy with heparin is the first-line treatment for acute mesenteric vein thrombosis and is effective in improving outcomes....
-
Inappropriate Combined Antiplatelet and Anticoagulant Therapy in Older Patients with Atrial Fibrillation: Trend over Time (2009–18)
Background and ObjectivesAntiplatelet therapy, when prescribed in combination with anticoagulant therapy to older patients with atrial fibrillation...
-
Assessing physicians’ knowledge, attitude, and practice on anticoagulant therapy in non-valvular atrial fibrillation: Syrian insights
BackgroundAtrial fibrillation (AF) is the most prevalent cardiac condition linked to increased mortality due to complications such as stroke. Oral...
-
Follow-up study of isolated calf muscular vein thrombosis for anticoagulant therapy after primary hip and knee arthroplasty
BackgroundAlthough isolated calf muscular vein thrombosis (ICMVT) is commonly seen after hip and knee arthroplasty, no treatment guidelines for ICMVT...
-
Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study
BackgroundThe role of anticoagulants in the treatment of cirrhotic PVT remains controversial. This study aimed to analyze the safety and efficacy of...
-
Role of Antiplatelet and Anticoagulant Therapy in Management of Peripheral Artery Disease
Purpose of reviewPeripheral arterial disease (PAD) is a complex atherosclerotic arterial disease with significant morbidity and mortality. Hence, the...
-
Predictive value of von Willebrand factor for venous thrombosis in patients with chronic heart failure complicated with atrial fibrillation after anticoagulant therapy
BackgroundWe investigated the value of von Willebrand factor (vWF) in predicting venous thrombosis in patients with chronic heart failure complicated...
-
Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis
This meta-analysis compared the efficacy and safety of different antithrombotic regimens after left atrial appendage closure (LAAC). PubMed, Embase,...
-
Management of Gastrointestinal Bleeding and Resumption of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation: A Multidisciplinary Discussion
Direct oral anticoagulants (DOACs) are recommended for the prevention of thromboembolism in patients with atrial fibrillation (AF), and are now...
-
Phenotype-oriented anticoagulant therapy for sepsis: still a work in progress
Coagulation disorders ranging from subtle changes in coagulation parameters to fatal disseminated intravascular coagulation (DIC) are common in...
-
Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: Rationale and Design of the ENBALV Trial
Background and PurposeAnticoagulant therapy with vitamin K antagonists is recommended within 3 to 6 months after bioprosthetic valve replacement to...
-
Immediate postoperative parenteral anticoagulant therapy in patients with mesenteric ischemia after intestinal resection: a retrospective cohort study at a single institute
BackgroundBowel gangrene represents a major fatal event in acute mesenteric ischemia. Intestinal resection is inevitable in patients with peritonitis...
-
Determining prognostic indicator for anticoagulant therapy in sepsis-induced disseminated intravascular coagulation
BackgroundThere is no reliable indicator that can assess the treatment effect of anticoagulant therapy for sepsis-associated disseminated...
-
Anticoagulant therapy and home blood pressure-associated risk for stroke/bleeding events in elderly patients with non-valvular atrial fibrillation: the sub-cohort study of ANAFIE registry
The benefits of direct oral anticoagulants (DOACs) and warfarin in elderly Japanese patients with non-valvular atrial fibrillation (NVAF) and high...
-
A case of pancreatic head cancer with Trousseau’s syndrome treated with radical resection and anticoagulant therapy
BackgroundThe primary disease of Trousseau’s syndrome is often highly advanced cancer, and treatment of the primary disease after cerebral infarction...
-
Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study
Limited evidence exists regarding management of recurrent venous thromboembolism (VTE) that occurs during anticoagulant therapy. We aimed to describe...
-
Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab
Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is a rare acquired bleeding disorder secondary to development of antibodies against...
-
Minimal is not minor also in patients with mild traumatic brain injury on oral direct anticoagulant therapy
Currently, all patients, regardless of the type of head injury, should undergo a head computerized tomography (CT) if on oral anticoagulant therapy....
-
A real-world exploration into clinical outcomes of direct oral anticoagulant therapy in people with chronic kidney disease: a large hospital-based study
BackgroundThere is limited evidence to support definite clinical outcomes of direct oral anticoagulant (DOAC) therapy in chronic kidney disease...
